vrc-eboadc069-00-vp
Vaccineexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 27, 2014 (NCT02231866)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- MarburgvirusImmunity, active
Marburgvirus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- vrc-eboadc069-00-vp
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02408913 | Phase 1 | Mar 26, 2015 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT02368119 | Phase 1 | Mar 1, 2015 | National Institute of Allergy and Infectious Diseases (NIAID), University of Maryland |
| NCT02231866 | Phase 1 | Aug 27, 2014 | National Institute of Allergy and Infectious Diseases (NIAID) |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 3 | 2 | 1 | 2014 |
| University of Maryland | Academic/Hospital | 1 | 1 | 1 | 2015 |
2 organizations
Page 1 / 1